Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain

Bioorg Med Chem. 2016 Nov 1;24(21):5028-5035. doi: 10.1016/j.bmc.2016.06.006. Epub 2016 Jun 4.

Abstract

A new series of aryls, including benzo[d]imidazole/isoxazole/pyrazole, conjugated to 3N-substituted-azabicyclo[3.1.0]hexane derivatives were designed and synthesized as inhibitors of T-type calcium channels. Among the synthesized compounds, 3N-R-substituted azabicyclo[3.1.0]hexane carboxamide derivatives containing 5-isobutyl-1-phenyl-pyrazole ring exhibited potent and selective T-channel inhibition and good metabolic stability without CYP450 inhibition. Compounds 10d and 10e contained hydrophobic substituents at the 3N-position and exhibited potent in vitro efficacy, as well as neuropathic pain alleviation in rats.

Keywords: 6-Pyrazoylamido-3-N-substituted-azabicyclo[3.1.0]hexane; Neuropathic pain; T-type calcium channel inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Azabicyclo Compounds / administration & dosage
  • Azabicyclo Compounds / chemical synthesis
  • Azabicyclo Compounds / chemistry
  • Azabicyclo Compounds / pharmacology*
  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / chemical synthesis
  • Calcium Channel Blockers / chemistry
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, T-Type / metabolism*
  • Disease Models, Animal
  • HEK293 Cells
  • Humans
  • Male
  • Neuralgia / drug therapy*
  • Neuralgia / metabolism
  • Pyrazoles / administration & dosage
  • Pyrazoles / chemical synthesis
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacology*
  • Rats
  • Structure-Activity Relationship

Substances

  • Azabicyclo Compounds
  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Pyrazoles